Genpact Ltd. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Genpact Ltd. has filed its Q1 2024 10-Q report detailing financial performance and position.</b>

AI Summary

Genpact LTD (G) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Genpact Ltd. filed a 10-Q report for the period ending March 31, 2024. The filing covers the first quarter of fiscal year 2024. The report includes financial data for the periods ending March 31, 2024, December 31, 2023, and March 31, 2023. Key financial statement components such as Common Stock, Additional Paid-In Capital, Retained Earnings, and Accumulated Other Comprehensive Income are detailed for various periods. The filing also references fair value measurements for recurring items as of December 31, 2023.

Why It Matters

For investors and stakeholders tracking Genpact LTD, this filing contains several important signals. This 10-Q provides investors with the latest quarterly financial results and disclosures, crucial for understanding the company's current performance and outlook. The detailed financial data allows for year-over-year and sequential comparisons, enabling stakeholders to assess trends in revenue, profitability, and balance sheet health.

Risk Assessment

Risk Level: low — Genpact LTD shows low risk based on this filing. The filing is a standard quarterly report (10-Q) with no immediate red flags, indicating routine disclosure of financial information.

Analyst Insight

Review the detailed financial statements and segment information within the 10-Q to assess Genpact's performance trends and identify any significant changes from prior periods.

Key Numbers

• 2024-03-31 — Period End Date (CONFORMED PERIOD OF REPORT)
• 2024-05-10 — Filing Date (FILED AS OF DATE)
• 2024 Q1 — Reporting Quarter (Reporting Period)

Key Players & Entities

• Genpact LTD (company) — FILER
• 2024-03-31 (date) — CONFORMED PERIOD OF REPORT
• 2024-05-10 (date) — FILED AS OF DATE
• 8742 (other) — STANDARD INDUSTRIAL CLASSIFICATION
• Hamilton (location) — CITY
• 001-33626 (other) — SEC FILE NUMBER

FAQ

Industry Context

Genpact operates in the business process management and digital transformation services industry.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring public companies to submit regular financial reports.

What Investors Should Do

1. Analyze the balance sheet for changes in assets, liabilities, and equity from the previous quarter.
2. Review any disclosed notes to the financial statements for specific details on accounting policies or significant transactions.
3. Compare key financial metrics presented in this 10-Q against historical data to identify performance trends.

Key Dates

• 2024-03-31: Quarterly Period End — End of the first quarter of fiscal year 2024.
• 2024-05-10: Filing Date — Date the 10-Q report was officially filed with the SEC.

Year-Over-Year Comparison

This filing represents the first quarterly report for fiscal year 2024, following the annual report (10-K) filed previously.

Key Financial Figures

• $0.01 — ch registered Common shares, par value $0.01 per share G New York Stock Exchange I

Filing Documents

• g-20240331.htm (10-Q) — 1510KB
• exhibit101-rsuawardagreeme.htm (EX-10.1) — 158KB
• exhibit102-psuawardagreeme.htm (EX-10.2) — 166KB
• g-20200930x10qex311.htm (EX-31.1) — 9KB
• g-20200930x10qex312.htm (EX-31.2) — 9KB
• g-20200930x10qex321.htm (EX-32.1) — 4KB
• g-20200930x10qex322.htm (EX-32.2) — 4KB
• 0001398659-24-000080.txt (&nbsp;) — 10481KB
• g-20240331.xsd (EX-101.SCH) — 90KB
• g-20240331_cal.xml (EX-101.CAL) — 105KB
• g-20240331_def.xml (EX-101.DEF) — 355KB
• g-20240331_lab.xml (EX-101.LAB) — 947KB
• g-20240331_pre.xml (EX-101.PRE) — 673KB
• g-20240331_htm.xml (XML) — 1528KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Unaudited Consolidated Financial Statements

Item 1. Unaudited Consolidated Financial Statements GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Balance Sheets (Unaudited) (In thousands, except per share data and share count) Notes As of December 31, 2023 As of March 31, 2024 Assets Current assets Cash and cash equivalents $ 583,670 $ 478,398 Accounts receivable, net of allowance for credit losses of $ 18,278 and $ 21,294 as of December 31, 2023 and March 31, 2024, respectively 3 1,116,273 1,147,233 Prepaid expenses and other current assets 6 191,566 204,811 Total current assets $ 1,891,509 $ 1,830,442 Property, plant and equipment, net 8 189,803 193,805 Operating lease right-of-use assets 186,167 199,118 Deferred tax assets 22 298,921 281,945 Intangible assets, net 9 53,028 46,305 Goodwill 9 1,683,782 1,679,720 Contract cost assets 19 202,543 204,918 Other assets, net of allowance for credit losses of $ 4,096 and $ 7,174 as of December 31, 2023 and March 31, 2024, respectively 299,960 304,389 Total assets $ 4,805,713 $ 4,740,642 Liabilities and equity Current liabilities Short-term borrowings 10 $ 10,000 $ 50,000 Current portion of long-term debt 11 432,242 425,768 Accounts payable 27,739 28,032 Income taxes payable 22 38,458 39,373 Accrued expenses and other current liabilities 12 759,180 595,350 Operating leases liability 50,313 46,879 Total current liabilities $ 1,317,932 $ 1,185,402 Long-term debt, less current portion 11 824,720 818,327 Operating leases liability 168,015 180,724 Deferred tax liabilities 22 11,706 11,589 Other liabilities 13 234,948 246,230 Total liabilities $ 2,557,321 $ 2,442,272 Shareholders' equity Preferred shares, $ 0.01 par value, 250,000,000 authorized, none issued — — Common shares, $ 0.01 par value, 500,000,000 authorized, 179,494,132 and 179,979,368 issued and outstanding as of December 31, 2023 and March 31, 2024, respectively 1,789 1,794 Additional paid-in capital 1,883,944 1,879,099 Retained earnings 1,085,209 1,144,671 Accu

View Full Filing

View this 10-Q filing on SEC EDGAR